For more information or confidential assistance
se habla español

New Study Reveals Need for Clinical Clarification of Testosterone Side Effects

Byetta pancreatic cancer patient
For aging men, testosterone replacement therapy can help combat some of the physiological symptoms of decreasing testosterone levels – a condition known as “Low-T.” However, much like female hormone replacement therapy, Low-T treatments have come under increasing scrutiny for potential side effects and unexpected life-threatening ailments in patients receiving therapy... Read more »

Deceptive Marketing at Crux of Androgel Lawsuit

The U.S. Food and Drug Administration has yet to approve any type of testosterone replacement therapy as a treatment for age-associated low testosterone levels, otherwise known as “Low T.” Yet manufacturers of testosterone supplements have aggressively marketed products like Androgel to thousands of middle aged American men who believed they... Read more »

New Study Reveals Testosterone Drug Risk

Byetta pancreatic cancer patient
Recent studies have provided conflicting and controversial results regarding testosterone drug risk to patients undergoing testosterone replacement therapy. However, a new report titled “Testosterone Therapy and Risk of Myocardial Infarction: A Pharmacoepidemiologic Study” published on January 13, found statistically significant results. Researchers Mahyar Etminan, Sean C. Skeldon, Sheldon Larry Goldenberg,... Read more »

Judge Determines Bellwether Process for Non-AndroGel Testosterone Injury Lawsuits

Byetta pancreatic cancer patient
U.S. District Judge Matthew Kennelly has prescribed a case management plan and process for preparing bellwether trials in testosterone injury lawsuits not involving AbbVie’s AndroGel product, but rather the various testosterone treatments marketed and sold by several other manufacturers. Judge Kennelly’s order further clarifies a specific area of distinction among... Read more »

EMA Study Highlights Testosterone Drug Risks

Byetta pancreatic cancer patient
The European Medicines Agency recently released a statement regarding testosterone drug risks for patients using drugs like Androgel, Axiron, AndroDerm and Testim. The November 21 statement noted that drugs should be used with caution, although researchers are still working to determine their link to health problems. The statement was released... Read more »

FDA Panel Backs New Testosterone Drug Safety Limits

Amid concerns over testosterone therapy side effects, an FDA panel has backed limitations on labeling for testosterone to exclude prescriptions for men who take the therapy only to counteract ordinary signs of aging rather than specific hormonal abnormalities. The panel also voted overwhelmingly to require clinical safety trials for some... Read more »

Preliminary Discovery Plan Outlined for Low T Drug Lawsuits

Byetta pancreatic cancer patient
Low T drug lawsuits alleging life-altering complications from Androgel, Testim and other testosterone supplements continue to mount in courtrooms across the nation. Plaintiffs claim they were inadequately warned about the risk of cardiovascular injury, stroke, heart attack and other severe health complications by the manufacturers of testosterone replacement products. A... Read more »